1 Morell P. A correlative synopsis of the leukodystrophies[J]. Neuropediatrics, 1984, 15 Suppl: 62-65. PMID: 6546165. DOI: 10.1055/s-2008-1052383.
2 Vanderver A, Prust M, Tonduti D, et al. Case definition and classification of leukodystrophies and leukoencephalopathies[J]. Mol Genet Metab, 2015, 114(4): 494-500. PMID: 25649058. PMCID: PMC4390457. DOI: 10.1016/j.ymgme.2015.01.006.
3 van der Knaap MS, Schiffmann R, Mochel F, et al. Diagnosis, prognosis, and treatment of leukodystrophies[J]. Lancet Neurol, 2019, 18(10): 962-972. PMID: 31307818. DOI: 10.1016/S1474-4422(19)30143-7.
4 Vanderver A, Hussey H, Schmidt JL, et al. Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders[J]. Semin Pediatr Neurol, 2012, 19(4): 219-223. PMID: 23245555. PMCID: PMC3797524. DOI: 10.1016/j.spen.2012.10.001.
5 Soderholm HE, Chapin AB, Bayrak-Toydemir P, et al. Elevated leukodystrophy incidence predicted from genomics databases[J]. Pediatr Neurol, 2020, 111: 66-69. PMID: 32951664. PMCID: PMC7506144. DOI: 10.1016/j.pediatrneurol.2020.06.005.
6 Javadikooshesh S, Zaimkohan H, Pourghorban P, et al. Pelizaeus-Merzbacher-like disease 1 caused by a novel mutation in GJC2 gene: a case report[J]. Iran J Med Sci, 2021, 46(6): 493-497. PMID: 34840390. PMCID: PMC8611227. DOI: 10.30476/IJMS.2021.87126.1736.
7 Ain Ul Batool S, Almatrafi A, Fadhli F, et al. A homozygous missense variant in the MLC1 gene underlies megalencephalic leukoencephalopathy with subcortical cysts in large kindred: heterozygous carriers show seizure and mild motor function deterioration[J]. Am J Med Genet A, 2022, 188(4): 1075-1082. PMID: 34918859. DOI: 10.1002/ajmg.a.62614.
8 Muirhead KJ, Clause AR, Schlachetzki Z, et al. Genome sequencing identifies three molecular diagnoses including a mosaic variant in the COL2A1 gene in an individual with Pol III-related leukodystrophy and Feingold syndrome[J]. Cold Spring Harb Mol Case Stud, 2021, 7(6): a006143. PMID: 34737199. PMCID: PMC8751417. DOI: 10.1101/mcs.a006143.
9 Yamamoto A, Fukumura S, Habata Y, et al. Novel HSD17B4 variants cause progressive leukodystrophy in childhood: case report and literature review[J]. Child Neurol Open, 2021, 8: 2329048X211048613. PMID: 34660840. PMCID: PMC8512218. DOI: 10.1177/2329048X211048613.
10 Schmidt JL, Pizzino A, Nicholl J, et al. Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing[J]. Am J Med Genet A, 2020, 182(8): 1906-1912. PMID: 32573057. DOI: 10.1002/ajmg.a.61641.
11 Ratti S, Rusciano I, Mongiorgi S, et al. Lamin B1 accumulation's effects on autosomal dominant leukodystrophy (ADLD): induction of reactivity in the astrocytes[J]. Cells, 2021, 10(10): 2566. PMID: 34685544. PMCID: PMC8534128. DOI: 10.3390/cells10102566.
12 Vanderver A, Simons C, Helman G, et al. Whole exome sequencing in patients with white matter abnormalities[J]. Ann Neurol, 2016, 79(6): 1031-1037. PMID: 27159321. PMCID: PMC5354169. DOI: 10.1002/ana.24650.
13 Shukla A, Kaur P, Narayanan DL, et al. Genetic disorders with central nervous system white matter abnormalities: an update[J]. Clin Genet, 2021, 99(1): 119-132. PMID: 33047326. DOI: 10.1111/cge.13863.
14 Bonkowsky JL, Keller S, AAP Section on Neurology , Council on Genetics. Leukodystrophies in children: diagnosis, care, and treatment[J]. Pediatrics, 2021, 148(3): e2021053126. PMID: 34426533. DOI: 10.1542/peds.2021-053126.
15 Ashrafi MR, Amanat M, Garshasbi M, et al. An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies[J]. Expert Rev Neurother, 2020, 20(1): 65-84. PMID: 31829048. DOI: 10.1080/14737175.2020.1699060.
16 Sarret C. Leukodystrophies and genetic leukoencephalopathies in children[J]. Rev Neurol (Paris), 2020, 176(1-2): 10-19. PMID: 31174885. DOI: 10.1016/j.neurol.2019.04.003.
17 van der Knaap MS, Bugiani M. Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms[J]. Acta Neuropathol, 2017, 134(3): 351-382. PMID: 28638987. PMCID: PMC5563342. DOI: 10.1007/s00401-017-1739-1.
18 Inoue K. Pelizaeus-Merzbacher disease: molecular and cellular pathologies and associated phenotypes[J]. Adv Exp Med Biol, 2019, 1190: 201-216. PMID: 31760646. DOI: 10.1007/978-981-32-9636-7_13.
19 Osório MJ, Goldman SA. Neurogenetics of Pelizaeus-Merzbacher disease[J]. Handb Clin Neurol, 2018, 148: 701-722. PMID: 29478609. PMCID: PMC8167836. DOI: 10.1016/B978-0-444-64076-5.00045-4.
20 Hagemann TL. Alexander disease: models, mechanisms, and medicine[J]. Curr Opin Neurobiol, 2022, 72: 140-147. PMID: 34826654. PMCID: PMC8901527. DOI: 10.1016/j.conb.2021.10.002.
21 Yoshida T. Clinical characteristics of Alexander disease[J]. Neurodegener Dis Manag, 2020, 10(5): 325-333. PMID: 32847470. DOI: 10.2217/nmt-2020-0022.
22 Shaimardanova AA, Chulpanova DS, Solovyeva VV, et al. Metachromatic leukodystrophy: diagnosis, modeling, and treatment approaches[J]. Front Med (Lausanne), 2020, 7: 576221. PMID: 33195324. PMCID: PMC7606900. DOI: 10.3389/fmed.2020.576221.
23 Ashrafi MR, Tavasoli AR. Childhood leukodystrophies: a literature review of updates on new definitions, classification, diagnostic approach and management[J]. Brain Dev, 2017, 39(5): 369-385. PMID: 28117190. DOI: 10.1016/j.braindev.2017.01.001.
24 K?hler W, Curiel J, Vanderver A. Adulthood leukodystrophies[J]. Nat Rev Neurol, 2018, 14(2): 94-105. PMID: 29302065. DOI: 10.1038/nrneurol.2017.175.
25 Parikh S, Bernard G, Leventer RJ, et al. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies[J]. Mol Genet Metab, 2015, 114(4): 501-515. PMID: 25655951. PMCID: PMC4390485. DOI: 10.1016/j.ymgme.2014.12.434.
26 Pouwels PJ, Vanderver A, Bernard G, et al. Hypomyelinating leukodystrophies: translational research progress and prospects[J]. Ann Neurol, 2014, 76(1): 5-19. PMID: 24916848. DOI: 10.1002/ana.24194.
27 Desai NK, Mullins ME. An imaging approach to diffuse white matter changes[J]. Radiol Clin North Am, 2014, 52(2): 263-278. PMID: 24582340. DOI: 10.1016/j.rcl.2013.11.006.
28 Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders[J]. Neurology, 2009, 72(8): 750-759. PMID: 19237705. PMCID: PMC2677542. DOI: 10.1212/01.wnl.0000343049.00540.c8.
29 Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing[J]. Proc Natl Acad Sci U S A, 2009, 106(45): 19096-19101. PMID: 19861545. PMCID: PMC2768590. DOI: 10.1073/pnas.0910672106.
30 Kunii M, Doi H, Ishii Y, et al. Genetic analysis of adult leukoencephalopathy patients using a custom-designed gene panel[J]. Clin Genet, 2018, 94(2): 232-238. PMID: 29700822. DOI: 10.1111/cge.13371.
31 Bick D, Jones M, Taylor SL, et al. Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases[J]. J Med Genet, 2019, 56(12): 783-791. PMID: 31023718. PMCID: PMC6929710. DOI: 10.1136/jmedgenet-2019-106111.
32 Boucher AA, Miller W, Shanley R, et al. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report[J]. Orphanet J Rare Dis, 2015, 10: 94. PMID: 26245762. PMCID: PMC4545855. DOI: 10.1186/s13023-015-0313-y.
33 Eichler F, Duncan C, Musolino PL, et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy[J]. N Engl J Med, 2017, 377(17): 1630-1638. PMID: 28976817. PMCID: PMC5708849. DOI: 10.1056/NEJMoa1700554.
34 Ghabash G, Wilkes J, Bonkowsky JL. National U.S. patient and transplant data for Krabbe disease[J]. Front Pediatr, 2021, 9: 764626. PMID: 34900869. PMCID: PMC8660087. DOI: 10.3389/fped.2021.764626.
35 Videb?k C, Stokholm J, Sengel?v H, et al. Allogenic hematopoietic stem cell transplantation in two siblings with adult metachromatic leukodystrophy and a systematic literature review[J]. JIMD Rep, 2021, 60(1): 96-104. PMID: 34258145. PMCID: PMC8260480. DOI: 10.1002/jmd2.12221.
36 Page KM, Stenger EO, Connelly JA, et al. Hematopoietic stem cell transplantation to treat leukodystrophies: clinical practice guidelines from the hunter's hope leukodystrophy care network[J]. Biol Blood Marrow Transplant, 2019, 25(12): e363-e374. PMID: 31499213. DOI: 10.1016/j.bbmt.2019.09.003.
37 Dooves S, Leferink PS, Krabbenborg S, et al. Cell replacement therapy improves pathological hallmarks in a mouse model of leukodystrophy vanishing white matter[J]. Stem Cell Reports, 2019, 12(3): 441-450. PMID: 30799272. PMCID: PMC6411482. DOI: 10.1016/j.stemcr.2019.01.018.
38 Moser AB, Liu Y, Shi X, et al. Drug discovery for X-linked adrenoleukodystrophy: an unbiased screen for compounds that lower very long-chain fatty acids[J]. J Cell Biochem, 2021, 122(10): 1337-1349. PMID: 34056752. DOI: 10.1002/jcb.30014.
39 Koshu K, Ikeda T, Tamura D, et al. Gallbladder cancer with ascites in a child with metachromatic leukodystrophy[J]. Brain Dev, 2021, 43(1): 140-143. PMID: 32855001. DOI: 10.1016/j.braindev.2020.08.002.
40 Zheng S, Lee PY, Wang J, et al. Interstitial lung disease and psoriasis in a child with Aicardi-Goutières syndrome[J]. Front Immunol, 2020, 11: 985. PMID: 32508843. PMCID: PMC7251162. DOI: 10.3389/fimmu.2020.00985.
41 Tong F, Wang J, Xiao R, et al. Application of next generation sequencing in the screening of monogenic diseases in China, 2021: a consensus among Chinese newborn screening experts[J]. World J Pediatr, 2022. PMID: 35292922. DOI: 10.1007/s12519-022-00522-8.